---
reference_id: "PMID:32399598"
title: "Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance/translation disorders (LARS2, TFAM)."
authors:
- Tucker EJ
- Rius R
- Jaillard S
- Bell K
- Lamont PJ
- Travessa A
- Dupont J
- Sampaio L
- Dulon J
- Vuillaumier-Barrot S
- Whalen S
- Isapof A
- Stojkovic T
- Quijano-Roy S
- Robevska G
- van den Bergen J
- Hanna C
- Simpson A
- Ayers K
- Thorburn DR
- Christodoulou J
- Touraine P
- Sinclair AH
journal: Hum Genet
year: '2020'
doi: 10.1007/s00439-020-02176-w
content_type: abstract_only
---

# Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance/translation disorders (LARS2, TFAM).
**Authors:** Tucker EJ, Rius R, Jaillard S, Bell K, Lamont PJ, Travessa A, Dupont J, Sampaio L, Dulon J, Vuillaumier-Barrot S, Whalen S, Isapof A, Stojkovic T, Quijano-Roy S, Robevska G, van den Bergen J, Hanna C, Simpson A, Ayers K, Thorburn DR, Christodoulou J, Touraine P, Sinclair AH
**Journal:** Hum Genet (2020)
**DOI:** [10.1007/s00439-020-02176-w](https://doi.org/10.1007/s00439-020-02176-w)

## Content

1. Hum Genet. 2020 Oct;139(10):1325-1343. doi: 10.1007/s00439-020-02176-w. Epub 
2020 May 12.

Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: 
a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA 
maintenance/translation disorders (LARS2, TFAM).

Tucker EJ(1)(2), Rius R(3)(4), Jaillard S(5)(6), Bell K(7), Lamont PJ(8), 
Travessa A(9), Dupont J(9), Sampaio L(10), Dulon J(11), Vuillaumier-Barrot 
S(12)(13), Whalen S(14), Isapof A(15), Stojkovic T(16), Quijano-Roy S(17), 
Robevska G(18), van den Bergen J(18), Hanna C(18)(19), Simpson A(20), Ayers 
K(18)(3), Thorburn DR(3)(4), Christodoulou J(3)(4)(21), Touraine P(11), Sinclair 
AH(22)(23).

Author information:
(1)Reproductive Development Group, Murdoch Children's Research Institute, 
Melbourne, Australia. elena.tucker@mcri.edu.au.
(2)Department of Paediatrics, University of Melbourne, Melbourne, Australia. 
elena.tucker@mcri.edu.au.
(3)Department of Paediatrics, University of Melbourne, Melbourne, Australia.
(4)Brain and Mitochondrial Research Group, Murdoch Children's Research 
Institute, Melbourne, Australia.
(5)Service de Cytogénétique et Biologie Cellulaire, CHU Rennes, 35033, Rennes, 
France.
(6)Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de Recherche en 
Santé, Environnement et Travail)-UMR_S 1085, 35000, Rennes, France.
(7)Department of Bioinformatics, Murdoch Children's Research Institute, 
Melbourne, Australia.
(8)Neurogenetic Unit, Royal Perth Hospital, Perth, WA, Australia.
(9)Serviço de Genética Médica, Departamento de Pediatria, Hospital de Santa 
Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de 
Medicina de Lisboa, Lisbon, Portugal.
(10)Departamento de Pediatria, Hospital de Santa Maria, Centro Hospitalar 
Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Unidade de 
Endocrinologia Pediátrica, Lisbon, Portugal.
(11)Department of Endocrinology and Reproductive Medicine, Centre de Référence 
des Maladies Endocriniennes Rares de la Croissance et du Développement, Centre 
des Pathologies Gynécologiques Rares, AP-HP, Sorbonne University Medicine, 
Paris, France.
(12)AP-HP, Biochimie et Génétique, Hôpital Bichat-Claude Bernard, Paris, France.
(13)INSERM U1149, Paris, France.
(14)AP-HP, UF de Génétique Clinique, Centre de Référence Maladies Rares 
Anomalies du Développement et Syndromes Malformatifs, Hôpital Armand Trousseau, 
Paris, France.
(15)Department Child Neurology and Reference Center for Neuromuscular Diseases 
"Nord/Est/Ile-de-France", GRC ConCer-LD, UPMC Univ Paris 06, Sorbonne 
Universités, FILNEMUS, 75012, Paris, France.
(16)APHP, Sorbonne University, Pitié-Salpêtrière Hospital, Nord/Est/Ile de 
France Neuromuscular Reference Center, Myology Institute, Paris, France.
(17)Centre de Référence Maladies Neuromusculaires, Service de Neurologie, 
Réanimation et Réeducation Pédiatriques, Hôpital Raymond Poincaré (APHP Paris 
Saclay, UVSQ), Garches, France.
(18)Reproductive Development Group, Murdoch Children's Research Institute, 
Melbourne, Australia.
(19)Department of Paediatric and Adolescent Gynaecology, Royal Children's 
Hospital, Melbourne, VIC, 3052, Australia.
(20)School of Allied Health, La Trobe University, Melbourne, Australia.
(21)Discipline of Child and Adolescent Health, Sydney Medical School, University 
of Sydney, Sydney, Australia.
(22)Reproductive Development Group, Murdoch Children's Research Institute, 
Melbourne, Australia. andrew.sinclair@mcri.edu.au.
(23)Department of Paediatrics, University of Melbourne, Melbourne, Australia. 
andrew.sinclair@mcri.edu.au.

Perrault syndrome is a rare heterogeneous condition characterised by 
sensorineural hearing loss and premature ovarian insufficiency. Additional 
neuromuscular pathology is observed in some patients. There are six genes in 
which variants are known to cause Perrault syndrome; however, these explain only 
a minority of cases. We investigated the genetic cause of Perrault syndrome in 
seven affected individuals from five different families, successfully 
identifying the cause in four patients. This included previously reported and 
novel causative variants in known Perrault syndrome genes, CLPP and LARS2, 
involved in mitochondrial proteolysis and mitochondrial translation, 
respectively. For the first time, we show that pathogenic variants in PEX6 can 
present clinically as Perrault syndrome. PEX6 encodes a peroxisomal biogenesis 
factor, and we demonstrate evidence of peroxisomal dysfunction in patient serum. 
This study consolidates the clinical overlap between Perrault syndrome and 
peroxisomal disorders, and highlights the need to consider ovarian function in 
individuals with atypical/mild peroxisomal disorders. The remaining patients had 
variants in candidate genes such as TFAM, involved in mtDNA transcription, 
replication, and packaging, and GGPS1 involved in mevalonate/coenzyme Q10 
biosynthesis and whose enzymatic product is required for mouse folliculogenesis. 
This genomic study highlights the diverse molecular landscape of this poorly 
understood syndrome.

DOI: 10.1007/s00439-020-02176-w
PMID: 32399598 [Indexed for MEDLINE]